New  	New  	 JJ	B-NP
non-pharmacological  	non-pharmacological  	 JJ	I-NP
treatment  	treatment  	 NN	I-NP
methods  	methods  	 NNS	I-NP
in  	in  	 IN	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
The  	The  	 DT	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
chronic  	chronic  	 JJ	B-NP
heart  	heart  	 NN	I-NP
failure  	failure  	 NN	I-NP
( 	( 	 -LRB-	O
CHF 	CHF 	 NNP	B-NP
)  	)  	 -RRB-	O
increases  	increases  	 NNS	O
with  	with  	 IN	O
the  	the  	 DT	O
aging  	aging  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
population  	population  	 NN	O
and  	and  	 CC	O
with  	with  	 IN	O
the  	the  	 DT	O
improvement  	improvement  	 NN	O
in  	in  	 IN	O
survival  	survival  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
hypertension 	hypertension 	 NN	O
,  	,  	 ,	O
coronary  	coronary  	 JJ	B-NP
heart  	heart  	 NN	I-NP
disease  	disease  	 NN	I-NP
and  	and  	 CC	O
diabetes 	diabetes 	 NN	O
,  	,  	 ,	O
diseases  	diseases  	 NNS	O
which  	which  	 WDT	O
constitute  	constitute  	 VBP	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
causes  	causes  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
CHF 	CHF 	 NNP	B-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
the  	the  	 DT	O
significant  	significant  	 JJ	O
improvement  	improvement  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
CHF 	CHF 	 NNP	B-NP
,  	,  	 ,	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
recent  	recent  	 JJ	O
years  	years  	 NNS	O
has  	has  	 VBZ	O
improved  	improved  	 VBN	O
slightly 	slightly 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
primary  	primary  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
method  	method  	 NN	I-NP
for  	for  	 IN	I-NP
chronic  	chronic  	 JJ	I-NP
heart  	heart  	 NN	I-NP
failure  	failure  	 NN	I-NP
is  	is  	 VBZ	O
pharmacotherapy 	pharmacotherapy 	 VBN	O
,  	,  	 ,	O
but  	but  	 CC	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
limitations 	limitations 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
existing  	existing  	 JJ	O
data  	data  	 NN	O
encourages  	encourages  	 VBZ	O
to  	to  	 TO	O
look  	look  	 VB	O
for  	for  	 IN	O
new  	new  	 JJ	O
treatment  	treatment  	 NN	B-NP
methods  	methods  	 NNS	I-NP
for  	for  	 IN	I-NP
CHF 	CHF 	 NNP	I-NP
,  	,  	 ,	O
replacing  	replacing  	 VBG	O
or  	or  	 CC	O
enhancing  	enhancing  	 VBG	O
traditional  	traditional  	 JJ	O
ones  	ones  	 NNS	B-NP
while  	while  	 IN	O
constituting  	constituting  	 VBG	O
a  	a  	 DT	O
low  	low  	 JJ	O
nuisance  	nuisance  	 NN	O
for  	for  	 IN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
New  	New  	 JJ	B-NP
non-pharmacological  	non-pharmacological  	 JJ	I-NP
methods 	methods 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	B-NP
therapies  	therapies  	 NNS	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
stem  	stem  	 JJ	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
molecular  	molecular  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
,  	,  	 ,	O
modern  	modern  	 JJ	O
devices  	devices  	 NNS	O
supporting  	supporting  	 VBG	O
the  	the  	 DT	O
heart  	heart  	 NN	O
such  	such  	 JJ	O
as  	as  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
contractility  	contractility  	 JJ	I-NP
modulation 	modulation 	 NN	I-NP
,  	,  	 ,	O
spinal  	spinal  	 JJ	B-NP
cord  	cord  	 NN	I-NP
stimulation 	stimulation 	 NN	I-NP
,  	,  	 ,	O
carotid  	carotid  	 FW	B-NP
sinus  	sinus  	 FW	I-NP
nerve  	nerve  	 FW	I-NP
stimulation 	stimulation 	 FW	I-NP
,  	,  	 ,	O
cervical  	cervical  	 NN	B-NP
and  	and  	 CC	O
intracardiac  	intracardiac  	 FW	B-NP
atrioventricular  	atrioventricular  	 FW	I-NP
nodal  	nodal  	 FW	I-NP
vagal  	vagal  	 FW	I-NP
stimulation 	stimulation 	 FW	I-NP
,  	,  	 ,	O
implantable  	implantable  	 JJ	B-NP
monitoring  	monitoring  	 NN	I-NP
devices  	devices  	 NNS	I-NP
and  	and  	 CC	O
wearable  	wearable  	 JJ	O
cardioverter-defibrillator  	cardioverter-defibrillator  	 JJ	B-NP
or  	or  	 CC	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
comorbid  	comorbid  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
hypertension  	hypertension  	 NN	O
and  	and  	 CC	O
sleep  	sleep  	 VB	O
dis-  	dis-  	 JJ	B-NP
orders  	orders  	 NNS	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
particular  	particular  	 JJ	O
importance 	importance 	 NN	O
.  	.  	 .	O
